About Hangzhou Jiuyuan Genetic Biopharmaceutic

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Pegfilgrastim, Liraglutide(recombinant)，Enoxaparin sodium, Fulvestrant, Interleukin-11, Palonosetron Hydrochloride, rhBMP-2 , Fosaprepitant dimeglumine. Our product pipeline include: Semaglutide (recombinant), Recombinant Hyaluronidase, Avatrombopag maleate, Bone repair material with rhBMP-2 - Bone repair, Romosozumab,Daratumumab, Emicizumab, Amylin analog, SIRPα- specific monoclonal antibody.

Certifications

CE
FDA
GMP
ISO
Other

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center

16 Jun 2026 - 18 Jun 2026
CPHI Milan 2026

Fiera Milano, Italy

6 Oct 2026 - 8 Oct 2026